| Chen, Jianghua |
NCT03902691: Study of the Efficacy and Safety of Pegol-Sihematide for Anemia in Patients With Chronic Kidney Disease on Dialysis |
|
|
| Completed | 3 | 372 | RoW | Pegol-Sihematide, ESPO | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Chronic Kidney Diseases | 02/21 | 05/22 | | |
NCT05629598: A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia . |
|
|
| Recruiting | 2 | 150 | RoW | Recombinant human erythropoietin injection, Human erythropoietin injection | Angde Biotech Pharmaceutical Co., Ltd. | Renal Anemia | 03/23 | 08/23 | | |
NCT05687890: A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease |
|
|
| Active, not recruiting | 2 | 255 | RoW | Placebo of SC0062, SC0062 low dose, SC0062 medium dose, SC0062 high dose | Biocity Biopharmaceutics Co., Ltd. | Diabetic Kidney Disease, IgA Nephropathy | 11/24 | 04/25 | | |
| Recruiting | N/A | 366 | Canada, RoW | | The George Institute, Peking University Institute of Nephrology | IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases | 07/27 | 07/27 | | |
| Shi, Wei |
Oxycodone, NCT06690307: Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy |
|
|
| Recruiting | 4 | 64 | RoW | patient controlled intravenous analgesia(PCIA) | Affiliated Hospital of Nantong University | Laparoscopic Hysterectomy | 12/25 | 07/26 | | |
CAPSTONE-1, NCT03711305: Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) |
|
|
| Active, not recruiting | 3 | 462 | RoW | SHR-1316, Carboplatin, Etoposide, Placebo | Jiangsu HengRui Medicine Co., Ltd. | Extensive-stage Small Cell Lung Cancer | 10/22 | 12/23 | | |
PYRAMID-1, NCT04447118 / 2020-000951-11: Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy |
|
|
| Active, not recruiting | 3 | 151 | Europe, US, RoW | Pyrotinib, Irene, Docetaxel, Docetaxel injection | Jiangsu HengRui Medicine Co., Ltd. | Non-squamous NSCLC, HER2 Exon 20 Mutation | 06/23 | 10/23 | | |
TQ05105-III-01, NCT06682169: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease |
|
|
| Recruiting | 3 | 182 | RoW | Rovadicitinib, Imatinib, Methotrexate, Mycophenolate mofetil, Rituximab | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Graft-versus-host Disease | 10/29 | 12/30 | | |
NCT05674539: Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome |
|
|
| Recruiting | 3 | 200 | RoW | Fludarabine and Busulfan, Fludara and Busulfex, Fludarabine and Melphalan, Busulfex and Fludara | Wuhan Union Hospital, China | Acute Myeloid Leukemia, Adult, Myelodysplastic Syndrome(MDS), Allogeneic Hematopoietic Stem Cell Transplantation | 01/25 | 06/25 | | |
NCT03085069: A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC |
|
|
| Active, not recruiting | 2 | 146 | RoW | SHR-1210 | Jiangsu HengRui Medicine Co., Ltd. | Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms Nec, Lung Disease, Respiratory Tract Disease, Neoplasm, Bronchial, Carcinoma, Bronchogenic | 08/20 | 08/23 | | |
| Recruiting | N/A | 50000 | RoW | | Shanghai University of Traditional Chinese Medicine, Wangjing Hospital, China Academy of Chinese Medical Sciences, Dongzhimen Hospital, Beijing, The First Affiliated Hospital of Guangzhou University of TCM, Guangdong Provincial Hospital of Traditional Chinese Medicine, Affiliated Hospital of Changchun University of Chinese Medicine, Gansu Provincial Hospital, Guangzhou Kingmed Diagnostics Co., Ltd., Shandong Provincial Hospital of Traditional Chinese Medicine, Yunnan Provincial Hospital of Traditional Chinese Medicine, Shenzhen Pingle Orthopedic Hospital, First People's Hospital of Nankang District, Ganzhou City | Osteoporosis | 10/26 | 10/28 | | |
| Yu, Xue Qing |
TECAS, NCT03909217: Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (). |
|
|
| Completed | 2/3 | 470 | RoW | TECAS Procedure, TECAS, Escitalopram, Escitalopram Oxalate Tablets, Insomnia medication, Benzo | The University of Hong Kong, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing First Hospital of integrated Chinese and Western Medicine, The First Hospital of Hebei Medical University, Southwest Medical University, Hospital of Traditional Chinese Medicine | Mild-to-moderate Depression | 07/21 | 12/21 | | |
| Recruiting | N/A | 3000 | RoW | | Beijing Hospital | Atherosclerosis, Cardiovascular Diseases, Coronary Artery Disease, Myocardial Ischemia, Stroke | 12/22 | 12/22 | | |
| Recruiting | N/A | 300 | RoW | Paclitaxel DCB | Beijing Hospital | Coronary Disease | 01/23 | 07/23 | | |
NCT04664439: Follow-up With CT-FFR in CHD Patients After DCB |
|
|
| Recruiting | N/A | 92 | RoW | CT-FFR | Beijing Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College | Coronary; Ischemic | 12/23 | 06/24 | | |
NCT05131191: CT-FFR for Coronary In-stent Stenosis Based on ISR-Net Algorithm |
|
|
| Active, not recruiting | N/A | 150 | RoW | CT-FFR measurement, FFRCT, invasive FFR, pressure wire | Beijing Hospital | Coronary Stent Occlusion | 01/24 | 06/24 | | |
NCT02954419: IgA Nephropathy Biomarkers Evaluation Study (INTEREST) |
|
|
| Recruiting | N/A | 2000 | RoW | No intervention | Sun Yat-sen University | IgA Nephropathy, Glomerular Diseases | 11/26 | 01/27 | | |
| Fu, Ping |
NCT06597201: Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. |
|
|
| Recruiting | 4 | 400 | RoW | amino acid (15) peritoneal dialysis solution, glucose peritoneal dialysis solution | Chengdu Qingshan Likang Pharmaceutical Co., Ltd | End Stage Renal Disease (ESRD) | 06/25 | 06/25 | | |
| Active, not recruiting | 3 | 404 | Europe, Canada, Japan, US, RoW | Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo | Chinook Therapeutics, Inc. | IgA Nephropathy, Immunoglobulin A Nephropathy | 12/26 | 12/26 | | |
NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease |
|
|
| Recruiting | 2 | 320 | RoW | SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan | Shanghai Pharmaceuticals Holding Co., Ltd | Diabetic Kidney Disease | 06/25 | 06/25 | | |
NCT05328843: Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function |
|
|
| Not yet recruiting | 1 | 24 | RoW | PB119 | PegBio Co., Ltd. | Type2Diabetes | 10/22 | 10/22 | | |
SCDB, NCT06422845: Peripheral Scoring Drug-coated Balloon in the Treatment of Hemodialysis Arteriovenous Fistula Stenosis |
|
|
| Recruiting | N/A | 328 | RoW | Dissolve AV Peripheral Scoring Drug-coated Balloon, Scoring Drug-coated Balloon | DK Medical Technology (Suzhou) Co., Ltd. | Arteriovenous Fistula Stenosis | 07/27 | 07/27 | | |
| Recruiting | N/A | 366 | Canada, RoW | | The George Institute, Peking University Institute of Nephrology | IgA Nephropathy, ESRD, Glomerulonephritis, Kidney Diseases | 07/27 | 07/27 | | |
| Zhang, Jin li |
NCT03359694: Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer |
|
|
| Not yet recruiting | 3 | 300 | RoW | DT group, Pegylated liposomal doxorubicin and Docetaxel, ET group, Conventional doxorubicin and Docetaxel, NX group, Navelbine and Xeloda | Tianjin Medical University Cancer Institute and Hospital | Susceptibility, Genetic, Chemotherapy Effect | 11/19 | 10/22 | | |
NCT04629846: Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel. |
|
|
| Completed | 3 | 517 | RoW | Trastuzumab, Herceptin®, QL1209, Recombinant anti-HER-2 domain Ⅱ humanized monoclonal antibody injection, Pertuzumab, Perjeta®, Docetaxel, Docetaxel injection, surgery | Qilu Pharmaceutical Co., Ltd. | Breast Cancer | 08/22 | 10/23 | | |
CLOVER, NCT03926091: Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer |
|
|
| Recruiting | 3 | 2172 | RoW | Docetaxel, docetaxel injection, Cyclophosphamide, Cyclophosphamide injection | Fudan University | Breast Cancer | 11/24 | 11/25 | | |
BENCH, NCT04939142: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) |
|
|
| Active, not recruiting | 3 | 150 | RoW | SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone) | Antengene Corporation | Relapsed or Refractory Multiple Myeloma | 07/24 | 10/24 | | |
BELIEVE-01, NCT05234684: A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma |
|
|
| Recruiting | 3 | 150 | RoW | Orelabrutinib + R-CHOP, ICP-022+ R-CHOP, Placebo + R-CHOP | Beijing InnoCare Pharma Tech Co., Ltd. | Diffuse Large B Cell Lymphoma (DLBCL) | 07/24 | 12/25 | | |
NCT04578613: ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL |
|
|
| Recruiting | 3 | 218 | RoW | ICP-022, Chlorambucil, Rituximab | Beijing InnoCare Pharma Tech Co., Ltd. | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 12/24 | 06/25 | | |
NCT03351062: Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer |
|
|
| Recruiting | 3 | 844 | RoW | Tamoxifen, Tamoxifen citrate, Toremifene, fareston | Chinese Anti-Cancer Association, Fudan University, Henan Cancer Hospital, The First Hospital of Jilin University, Southwest Hospital, China, First Hospital of China Medical University, Guangdong Provincial People's Hospital, Harbin Medical University, First Affiliated Hospital of Chongqing Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Jiangsu Provincial People's Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Zhejiang Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, Union hospital of Fujian Medical University, Hebei Tumor Hospital, Hunan Cancer Hospital, Affiliated Hospital of Qinghai University, Wuhan TongJi Hospital, Hainan People's Hospital, The Third Affiliated Hospital of Kunming Medical College., The Third Affiliated Hospital of Nanchang University | Breast Cancer Female | 12/25 | 12/25 | | |
EMBER-4, NCT05514054: A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer |
|
|
| Recruiting | 3 | 6000 | Europe, Canada, Japan, US, RoW | Imlunestrant, LY3484356, Tamoxifen, Anastrozole, Letrozole, Exemestane | Eli Lilly and Company | Breast Neoplasms | 10/27 | 03/32 | | |
NCT06227117: Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast Cancer |
|
|
| Recruiting | 2 | 120 | RoW | Disitamab Vedotin Injection （18 weeks）, DV,RC48-ADC, Toripalimab （18weeks）, JS001, Carboplatin, Disitamab Vedotin Injection （12 weeks）, Sequential Epirubicin, Epirubicin, Sequential CTX, CTX, cyclophosphamide, Toripalimab （12weeks） | RemeGen Co., Ltd. | Breast Cancer | 12/25 | 12/26 | | |
NCT04562870 / 2020-003809-60: A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants with Previously Treated Myelofibrosis |
|
|
| Active, not recruiting | 2 | 112 | Europe, US, RoW | Selinexor, Physician's Choice Treatment | Karyopharm Therapeutics Inc | Myelofibrosis | 01/25 | 01/25 | | |
|
|
NCT03955978: TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer |
|
|
| Active, not recruiting | 1 | 10 | US | TSR-042, Brachytherapy, Endometrial biopsy, Blood draw for immune response | Washington University School of Medicine, Tesaro, Inc. | Endometrial Cancer, Cancer of the Endometrium | 03/24 | 12/25 | | |
| Not yet recruiting | N/A | 402 | NA | S-ketamine, esketamine, normal saline, physiological saline | Beijing Obstetrics and Gynecology Hospital, China Health Promotion Foundation, Beijing Haidian Maternal and Child Health Hospital, Obstetrics & Gynecology Hospital of Fudan University, Fourth Hospital of Shijiazhuang City, Changzhi Maternal and Child Health Hospital, Linfen Maternity&Child Healthcare Hospital, Maternal and Child Health Hospital, Jiading District, Tongzhou Maternal and Child Healthcare Hospital of Beijing, Beijing Chaoyang District Maternal and Child Health Care Hospital | Anesthesia, Analgesia, Depression, Cesarean Section, Parturition | 12/21 | 07/22 | | |
NCT04940091: Epidural Analgesia and Maternal Fever During Labor |
|
|
| Recruiting | N/A | 780 | RoW | Epidural analgesia, No other intervention | Peking University First Hospital, Guangdong Women and Children Hospital, Tangshan Maternal and Child Health Hospital, Dongguan Maternal and Child Health Hospital, Beijing Haidian Maternal and Child Health Hospital, Beijing Fuxing Hospital, Fourth Hospital of Shijiazhuang City, Xiamen Maternity & Child Care Hospital | Epidural Analgesia, Analgesic Effect, Fever | 09/22 | 10/22 | | |
NCT04582955: Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy |
|
|
| Recruiting | N/A | 20 | RoW | Chidamide in combination with chemotherapy, Other Name: For Chidamide: HBI-8000, CS055 | Tianjin Medical University Cancer Institute and Hospital | Triple-negative Breast Cancer | 12/22 | 12/22 | | |
NCT02506361: Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer |
|
|
| Recruiting | N/A | 800 | RoW | | Tianjin Medical University Cancer Institute and Hospital | Breast Cancer | 05/25 | 10/25 | | |
NCT05534854: Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes |
|
|
| Recruiting | N/A | 500 | RoW | Gene test | RenJi Hospital, Ruijin Hospital, Shanghai Zhongshan Hospital, Huashan Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Zhejiang Provincial People's Hospital, Tongji Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Shanghai 10th People's Hospital, First Affiliated Hospital, Sun Yat-Sen University, Peking University First Hospital | Renal Tumor Histology, Kidney Cancer, Renal Cell Carcinoma, Familial Renal Cancer, HLRCC, VHL Syndrome, BAP1 Tumor Predisposition Syndrome, FLCN Gene Mutation, ALK Gene Mutation, FH Gene Mutation, Birt-Hogg-Dube Syndrome, MET Gene Mutation, Cutaneous Leiomyoma, Cutaneous Leiomyomata With Uterine Leiomyomata | 08/25 | 08/25 | | |
| Chen, Jian |
NCT03521986: Pain and Quality of Life After Mediastinal Tumor Resection by Subxiphoid and Intercostal VATS |
|
|
| Recruiting | 3 | 100 | RoW | Subxiphoid uniportal VATS, Intercostal uniportal VATS | Lei Jiang | Mediastinal Neoplasms, Thoracic Neoplasm, Thoracic Surgery | 10/23 | 10/23 | | |
NCT03523468: Curative Effect and Quality of Life Between Uniportal and Open Sleeve Lobectomy for Central Type Lung Cancer |
|
|
| Recruiting | 3 | 200 | RoW | uniportal sleeve lobectomy, open sleeve lobectomy | Lei Jiang, Shanghai Pulmonary Hospital, Shanghai, China | Video-Assisted Thoracic Surgery, Lung Cancer | 05/24 | 12/24 | | |
NCT06205927: Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 77 | RoW | Standard carbon ion beam radiotherapy, Carbon ion beam radiotherapy simultaneously dose boost | Jian Chen | Non-small Cell Lung Cancer | 12/24 | 12/26 | | |
NCT06186726: Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors |
|
|
| Recruiting | 2 | 48 | RoW | carbon ion radiotherapy | Jian Chen | Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy | 12/26 | 12/29 | | |
NCT06311981: Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients |
|
|
| Recruiting | 2 | 29 | RoW | carbon ion radiotherapy, targeted therapy, single regimen chemotherapy in sequence with radiotherapy | Jian Chen | Non-small Cell Lung Cancer, Older People, Carbon Ion Radiotherapy, Radiotherapy Side Effect | 06/25 | 06/26 | | |
NCT06311955: Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor |
|
|
| Recruiting | 2 | 48 | RoW | Carbon ion radiotherapy, combined with platinum-based regimen | Jian Chen | Thymic Epithelial Tumor, Radiotherapy Side Effect, Carbon Ion Radiotheray, Heavy Ion Radiotherapy | 02/28 | 02/29 | | |
NCT06311968: The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor |
|
|
| Recruiting | 2 | 55 | RoW | Proton radiotherapy, combined platinum based chemotherapy | Jian Chen | Thymus Epithelial Tumor, Proton Radiotherapy, Radiation Toxicity | 02/27 | 02/27 | | |
SPH5030-201, NCT06434597: A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients. |
|
|
| Recruiting | 2 | 60 | RoW | SPH5030 | Shanghai Pharmaceuticals Holding Co., Ltd | Biliary Tract or Colorectal Cancer With Her2-positive/Mutated | 12/26 | 12/26 | | |
NCT05613452: Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer |
|
|
| Recruiting | 2 | 43 | RoW | Carbon ion beam radiotherapy | Shanghai Proton and Heavy Ion Center | Non-small Cell Lung Cancer | 01/25 | 01/26 | | |
NCT05715931: Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma |
|
|
| Recruiting | 2 | 30 | RoW | Toripalimab, Trastuzumab, 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT) | Yu jiren | Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer | 03/25 | 03/28 | | |
NCT05729646: Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma |
|
|
| Recruiting | 2 | 90 | RoW | Toripalimab, Oxaliplatin, S1 | Yu jiren | Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Mismatch Repair Deficiency | 02/26 | 02/29 | | |
NCT05872685: Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) |
|
|
| Recruiting | 2 | 314 | RoW | S1, Oxaliplatin, Serplulimab, Placebo | Yu jiren | Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair | 04/26 | 04/29 | | |
NCT05970627: Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma |
|
|
| Not yet recruiting | 2 | 30 | RoW | Toripalimab, Oxaliplatin, S1 | Yu jiren | Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma | 07/26 | 07/29 | | |
NCT05688488: Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords |
|
|
| Recruiting | 1/2 | 100 | RoW | Curcumin, Mitomycin-C | Eye & ENT Hospital of Fudan University | Glottic Web of Larynx, Laryngeal Stenosis, Glottic Carcinoma, Laryngeal Leucoplakia, Laryngeal Polyp, Laryngeal Papilloma | 12/25 | 12/26 | | |
| Recruiting | 1 | 150 | RoW | GQ1005 | GeneQuantum Healthcare (Suzhou) Co., Ltd. | HER2 Expressing or Mutated Advanced Malignant Solid Tumors | 12/24 | 07/25 | | |
NCT06614686: U87 CAR-T in Patients With Advanced Head and Neck Tumors |
|
|
| Recruiting | 1 | 20 | RoW | U87 autologous CAR T-cell | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | Nasopharynx Cancer, Head and Neck Cancer | 10/26 | 12/27 | | |
NCT05685719: A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558 |
|
|
| Completed | 1 | 37 | RoW | STI-1558, Itraconazole, Rifampin | Zhejiang ACEA Pharmaceutical Co. Ltd. | COVID-19 Pneumonia | 03/23 | 11/23 | | |
NCT05627063: A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 169 | US, RoW | ABSK121-NX | Abbisko Therapeutics Co, Ltd | Solid Tumor | 03/25 | 06/25 | | |
| Recruiting | 1 | 54 | RoW | HF1K16 /Arm 45 mg/m², HF1K16 /Arm 90 mg/m², HF1K16 /Arm 120 mg/m², HF1K16 /Arm 160 mg/m², HF1K16 /Arm 120 mg or 180 mg | HighField Biopharmaceuticals Corporation, Tigermed Consulting Co., Ltd | Solid Tumor, Adult | 04/25 | 11/25 | | |
NCT05861895: A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors |
|
|
| Recruiting | 1 | 84 | US | HF158K1 /Arm 2 mg/m², Infusion, HF158K1 /Arm 6 mg/m², HF158K1 /Arm 15 mg/m², HF158K1 /Arm 30 mg/m², HF158K1 /Arm 45 mg/m², HF158K1 /Arm 60 mg/m² | HighField Biopharmaceuticals Corporation | Solid Tumors, Adult | 04/25 | 12/25 | | |
NCT05827328: Explore the Optimal Surgical Timing for Lung Surgery and Mediastinal Surgery After COVID-19 Infection |
|
|
| Completed | N/A | 2000 | RoW | Observation | Shanghai Pulmonary Hospital, Shanghai, China | Thoracic Diseases, Thoracic Surgery | 06/23 | 06/23 | | |
NCT06340295: A Multicenter, Prospective Cohort Study of Preserved Ratio Impaired Spirometry(PRISm) in a Population |
|
|
| Recruiting | N/A | 2000 | RoW | | Peking University First Hospital, Shanxi Bethune Hospital, First Affiliated Hospital Xi'an Jiaotong University, Tianjin Medical University General Hospital, The First Hospital of Qinhuangdao, Shandong Provincial Hospital, Second Hospital of Jilin University, People's Hospital of Xinjiang Uygur Autonomous Region, MinDong Hospital of Ningde City | COPD | 05/26 | 05/26 | | |
| Recruiting | N/A | 150 | RoW | Consumer wearable device | Peking University First Hospital | COPD | 09/23 | 09/23 | | |
CHENJIAN1, NCT06126393: MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer |
|
|
| Not yet recruiting | N/A | 350 | RoW | next generation sequencing AND Immunohistochemical examination, Magnetic resonance examination | Fujian Cancer Hospital, Fujian Provincial Hospital, First Affiliated Hospital of Fujian Medical University, Gutian Hospital | Endometrial Neoplasms | 03/27 | 06/27 | | |
NCT06396143: Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration |
|
|
| Recruiting | N/A | 120 | RoW | | Zhejiang University | Locally Advanced Gastric Carcinoma | 06/25 | 12/25 | | |
NCT06551675: Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery |
|
|
| Recruiting | N/A | 120 | RoW | Silkworm pupa tablets, Control product | Xiaosun Liu, MD | Nutritional Deficiency, Gastrointestinal Cancer, Frailty Syndrome | 11/25 | 11/25 | | |
NCT06140589: Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer |
|
|
| Recruiting | N/A | 200 | RoW | Cadonilimab | Fujian Cancer Hospital, Fujian Medical University Affiliated Nanping First Hospital, The First Hospital Affiliated to Fujian Medical University, Fujian Medical University Union Hospital, Gutian Hospital, Jiangxi Provincial Cancer Hospital, Shunde Women and Children's Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan), Lianyungang Donghai County People's Hospital, Changsha Maternal and Child Health Hospital, Pingxiang Maternal and Child Health Hospital, Huinan County People's Hospital, People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine | Cervical Cancer | 12/24 | 12/26 | | |
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden |
|
|
| Recruiting | N/A | 3838 | RoW | Thrombus aspiration, PCI Alone | Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital | ST-segment Elevation Myocardial Infarction (STEMI) | 08/25 | 02/26 | | |
NCT04912401: the Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis |
|
|
| Recruiting | N/A | 100 | RoW | | Second Affiliated Hospital, School of Medicine, Zhejiang University | Psoriasis, Etanercept | 12/25 | 12/25 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
REPAIR PERS-AF, NCT06098989: A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation ( Study) |
|
|
| Not yet recruiting | N/A | 150 | NA | Radio frequency ablation | Haukeland University Hospital, St. Olavs Hospital, University Hospital of North Norway | Atrial Fibrillation, Persistent, Atrial Fibrillation Recurrent | 11/26 | 11/26 | | |
NCT05540821: Efficacy of Double Contrast-enhanced Ultrasound of Pelvic in Preoperative Evaluation of Deep Endometriosis |
|
|
| Recruiting | N/A | 156 | RoW | Hysterosalpingo-contrast sonography and sonoPODography | Shenzhen Second People's Hospital | Deep Endometriosis | 06/25 | 06/25 | | |
NCT05697926: Preclinical Research for Personalized TCR-T Therapy for Head and Neck Cancer |
|
|
| Recruiting | N/A | 100 | RoW | No intervention | Eye & ENT Hospital of Fudan University | Head and Neck Cancer | 12/25 | 06/26 | | |
| Fu, Jun zhou |
NCT04543461: American Lung Association (ALA) Lung Health Cohort |
|
|
| Recruiting | N/A | 4000 | US | | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), American Lung Association, Stanford University | Lung Diseases | 09/26 | 09/26 | | |
| Active, not recruiting | N/A | 300 | US | Medication Therapy Management (MTM) Video Telehealthcare, Electronic Adherence Self-Management (EAM) | Johns Hopkins University, Nemours Children's Health System, American Lung Association, National Heart, Lung, and Blood Institute (NHLBI) | Uncontrolled Asthma, Young Adults | 01/25 | 06/25 | | |
| Liu, Zheng rong |
NCT05080322: Efficacy and Safety of On-demand and Continuous Administration of Nasal Spray in the Treatment of Allergic Rhinitis |
|
|
| Recruiting | 4 | 150 | RoW | Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Azelastine Nasal 140 Mcg/Inh Nasal Spray, Flixonase,H20140117, AZEP,H20150201, Fluticasone Nasal 50 Mcg/Inh Nasal Spray, Flixonase,H20140117 | Zheng Liu ENT, Wuhan Union Hospital, China, Zhongnan Hospital, The People's Hospital of Hebei Province | Allergic Rhinitis | 12/24 | 01/25 | | |
SAST, NCT04088513: Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency |
|
|
| Recruiting | 4 | 440 | RoW | Aspirin, Acetylsalicylic acid, Clopidogrel, Plavix | First Affiliated Hospital, Sun Yat-Sen University | G6PD Deficiency, Stroke | 12/24 | 12/24 | | |
NCT03431428: Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients |
|
|
| Recruiting | 3 | 477 | RoW | transanal surgery, Miles surgery, Preoperative chemoradiotherapy | Zhang Rui | Almost-cCR, Surgery, Rectal Cancer | 01/20 | 12/22 | | |
NCT06200766: A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis |
|
|
| Recruiting | 3 | 640 | RoW | Mometasone furoate as a nasal spray | Zheng Liu ENT, Zhejiang Xianju Pharma Tech. Co., Ltd | Seasonal Allergic Rhinitis | 04/24 | 06/24 | | |
NCT06364904: An Phase III Study, Multicenter，Randomized Controlled Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma. |
|
|
| Not yet recruiting | 3 | 210 | RoW | Tislelizumab, Cisplatin, Gemcitabine and Trilaciclib, Tislelizumab, Cisplatin, Gemcitabine | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Bladder Cancer | 04/27 | 04/29 | | |
NCT05844150: A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC |
|
|
| Recruiting | 2/3 | 445 | RoW | PM8002, Platinum, Atezolizumab, Etoposide | Biotheus Inc. | SCLC | 06/25 | 12/25 | | |
NCT06315426: A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). |
|
|
| Not yet recruiting | 2 | 90 | NA | GR1802 injection, Placebo | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Allergic Rhinitis | 10/24 | 12/24 | | |
| Recruiting | 2 | 20 | RoW | zanubrutinib | Xuanwu Hospital, Beijing | Neuromyelitis Optica | 10/24 | 10/24 | | |
NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis |
|
|
| Not yet recruiting | 2 | 168 | RoW | TQH2722 injection, TQH2722 Placebo | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Seasonal Allergic Rhinitis | 06/25 | 08/25 | | |
NCT06364956: Phase Ib/II Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma |
|
|
| Recruiting | 1/2 | 36 | RoW | Tislelizumab combined with two predefined dose groups of palbociclib, RP2D dose Of Tislelizumab combined with palbociclib was selected for phase II clinical trial. | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Bladder Cancer | 06/25 | 06/26 | | |
NCT05009134: Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination |
|
|
| Recruiting | N/A | 120 | RoW | There is no intervention in this study. | Huazhong University of Science and Technology, National Natural Science Foundation of China | Allergic Rhinitis, Allergen Immunotherapy, SARS-CoV-2 | 03/22 | 04/22 | | |
NCT05983003: Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data |
|
|
| Completed | N/A | 3500 | RoW | endoscopic sinus surgery, ESS | Zheng Liu | Chronic Sinusitis, Radiology, Pathology, Surgery, Progression | 04/24 | 04/24 | | |
EMRESSECRS, NCT04852562: The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps |
|
|
| Recruiting | N/A | 110 | RoW | Modified radical endoscopic sinus surgery, MRESS, functional endoscopic sinus surgery, FESS | Zheng Liu | Chronic Sinusitis, Endoscopic Sinus Surgery, Nasal Polyps | 12/23 | 12/24 | | |
NCT06198894: Steroid-eluting Sinus Stent for Chronic Rhinosinusitis Patients With Uncontrolled Postoperative Symptoms |
|
|
| Recruiting | N/A | 96 | RoW | steroid-eluting sinus stent implant, BISORB bioabsorbable steroid-eluting sinus stent, Systemic glucocorticoids, Medrol, saline irrigations, 0.9% sodium chloride solution, Placebo, Systemic glucocorticoid placebo, sham procedure, In-office bilateral sham procedure of stent placement | Zheng Liu | Chronic Sinusitis | 01/26 | 04/26 | | |
NCT06240104: Monitoring of Heart to Guide Myocardial Injury Patients to Wean From Ventilation |
|
|
| Recruiting | N/A | 200 | RoW | cardiac output index monitor | Peking University People's Hospital | Myocardial Ischaemia During Surgery | 12/25 | 12/25 | | |
NCT06370468: The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis |
|
|
| Recruiting | N/A | 150000 | RoW | Epidemiological investigation | Zheng Liu ENT, Peking Union Medical College, Hainan People's Hospital, Shandong Second Provincial General Hospital, First Affiliated Hospital of Chongqing Medical University, First Affiliated Hospital of Xinjiang Medical University | Chronic Rhinitis | 05/27 | 08/27 | | |
NCT06474923: Multimodal Data-assisted Primary Screening for Allergic Rhinitis Based on Voice Recognition and Face Recognition |
|
|
| Recruiting | N/A | 1500 | RoW | Face image and voice audio | Zheng Liu | Body Image, Speech Sound Disorder | 12/24 | 06/25 | | |
NCT06462417: Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis |
|
|
| Not yet recruiting | N/A | 15 | RoW | Arbidol, Arbidol Hydrochloride | Zheng Liu, National Natural Science Foundation of China | Allergic Rhinitis | 06/25 | 06/25 | | |
CATHEDRAL, NCT05134129: Correlation Between Targeted HbA1c Values and Prevention of Recurrent Cardiovascular Events in Type 2 Diabetes After PCI |
|
|
| Recruiting | N/A | 1500 | RoW | | Shanghai 10th People's Hospital | Diabetes Mellitus, Percutaneous Coronary Intervention | 09/24 | 09/24 | | |
NCT05444491: Application of Polygenic Methylation Markers in Postoperative Recurrence Monitoring of Colorectal Cancer |
|
|
| Recruiting | N/A | 1200 | RoW | | Singlera Genomics Inc., Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Colorectal Cancer | 06/25 | 06/25 | | |
| Yu, Xueqing |
AURORA, NCT03214731: Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis |
|
|
| Recruiting | 4 | 90 | RoW | Artesunate, Art, placebo | Sun Yat-sen University, The First People's Hospital of Yunnan, The First Affiliated Hospital of Nanchang University, General Hospital of Ningxia Medical University, First Affiliated Hospital of Fujian Medical University, Shenzhen Second People's Hospital, The Third Xiangya Hospital of Central South University, Tongji Hospital | Lupus Nephritis | 09/22 | 09/22 | | |
LUMINA, NCT03200210: Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients |
|
|
| Recruiting | 4 | 548 | RoW | Febuxostat, Febuxostat Tablets, Placebo | Sun Yat-sen University | Hyperuricemia | 12/22 | 12/22 | | |
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED ) |
|
|
| Recruiting | 4 | 9000 | RoW | Aspirin 100 mg Oral Tablet, Matching Placebo | Guangdong Provincial People's Hospital, The George Institute | CKD (Chronic Kidney Disease) Stage 5D | 09/26 | 12/26 | | |
NCT06016036: SAL-0951 Tablets in the Treatment of Renal Anemia in Non-dialysis Chronic Kidney Disease |
|
|
| Completed | 3 | 156 | RoW | SAL-0951, SAL-0951 group, Placebo, Placebo phase | Shenzhen Salubris Pharmaceuticals Co., Ltd. | Renal Anemia in Non-dialysis Chronic Kidney Disease | 10/21 | 02/22 | | |
| Recruiting | 3 | 486 | RoW | SHR6508 plus oral placebo tablets, Cinacalcet plus intravenous placebo | Shanghai Hengrui Pharmaceutical Co., Ltd. | Secondary Hyperparathyroidism | 06/25 | 07/25 | | |
NCT05663411: A Study of SHR6508 in Secondary Hyperparathyroidism |
|
|
| Active, not recruiting | 2 | 75 | RoW | SHR6508, Cinacalcet | Shanghai Hengrui Pharmaceutical Co., Ltd. | Secondary Hyperparathyroidism | 10/23 | 11/23 | | |
